OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BODA58

Bodal Chemicals Ltd

Specialty ChemicalsVerified

Bodal Chemicals Ltd has a debt-to-equity ratio of 0.82, indicating a moderate level of leverage, and a current ratio of 1.17, suggesting limited short-term liquidity cushion. The company's liquidity position is assessed as medium risk, with net cash negative after subtracting total debt. Free cash flow stands at INR 405.05 million, while capital expenditure is negative at INR 46.45 million, indicating potential asset sales or non-cash capital outflows. Profitability metrics show a return on equity (ROE) of 1.67% and a return on assets (ROA) of 0.79%, both below the typical thresholds for industry-leading performance. The company's operating income of INR 918.48 million and net income of INR 185.02 million reflect a narrow margin structure, with gross profit at INR 4.74 billion. These figures suggest a need for cost optimization or pricing power enhancement to align with industry benchmarks. The company's revenue is derived from five business divisions: dye intermediates, dyestuff, sulphur & bulk chemicals, water purification, and chlor alkali. The dye intermediate division produces approximately 25 variants, with VINYL SUPHONE as the core product, while the dyestuff division produces 175 variants used in textiles, leather, and paper industries. The geographic exposure and customer concentration are not explicitly disclosed, but the company's product applications suggest broad industrial use across sectors. Outlook for the current fiscal year indicates a stable revenue trajectory, with no significant growth or contraction expected. The company's revenue of INR 17.45 billion is in line with analyst estimates, and no numeric deltas are provided for the next fiscal year. The absence of a clear growth trajectory suggests a conservative or maintenance mode of operations. Risk factors include medium liquidity risk and low dilution risk. The company's capital structure is supported by INR 9.11 billion in long-term debt and INR 11.05 billion in total equity. No dilution sources are identified in the risk assessment, and the dilution potential is assessed as low. Recent events include the latest financial filing, which shows a revenue of INR 17.45 billion and an EPS of INR 1.57. No significant regulatory or operational events are disclosed in the latest filings, and the company's risk profile remains stable.

30-day price · BODA+17.88 (+32.6%)
Low$50.55High$76.40Close$72.80As of12 May, 00:00 UTC
Profile
CompanyBodal Chemicals Ltd
TickerBODA.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Bodal Chemicals Ltd is engaged in the business of manufacturing dyes, dye intermediates, and basic chemicals, including products such as sulphuric acid, chlorosulphonic acid, and Trichloroisocyanuric Acid (TCCA 90).

Classification. Bodal Chemicals Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Bodal Chemicals Ltd has a debt-to-equity ratio of 0.82, indicating a moderate level of leverage, and a current ratio of 1.17, suggesting limited short-term liquidity cushion. The company's liquidity position is assessed as medium risk, with net cash negative after subtracting total debt. Free cash flow stands at INR 405.05 million, while capital expenditure is negative at INR 46.45 million, indicating potential asset sales or non-cash capital outflows. Profitability metrics show a return on equity (ROE) of 1.67% and a return on assets (ROA) of 0.79%, both below the typical thresholds for industry-leading performance. The company's operating income of INR 918.48 million and net income of INR 185.02 million reflect a narrow margin structure, with gross profit at INR 4.74 billion. These figures suggest a need for cost optimization or pricing power enhancement to align with industry benchmarks. The company's revenue is derived from five business divisions: dye intermediates, dyestuff, sulphur & bulk chemicals, water purification, and chlor alkali. The dye intermediate division produces approximately 25 variants, with VINYL SUPHONE as the core product, while the dyestuff division produces 175 variants used in textiles, leather, and paper industries. The geographic exposure and customer concentration are not explicitly disclosed, but the company's product applications suggest broad industrial use across sectors. Outlook for the current fiscal year indicates a stable revenue trajectory, with no significant growth or contraction expected. The company's revenue of INR 17.45 billion is in line with analyst estimates, and no numeric deltas are provided for the next fiscal year. The absence of a clear growth trajectory suggests a conservative or maintenance mode of operations. Risk factors include medium liquidity risk and low dilution risk. The company's capital structure is supported by INR 9.11 billion in long-term debt and INR 11.05 billion in total equity. No dilution sources are identified in the risk assessment, and the dilution potential is assessed as low. Recent events include the latest financial filing, which shows a revenue of INR 17.45 billion and an EPS of INR 1.57. No significant regulatory or operational events are disclosed in the latest filings, and the company's risk profile remains stable.
Key takeaways
  • Bodal Chemicals Ltd operates with a moderate debt load and limited liquidity cushion.
  • Profitability metrics are below industry-leading benchmarks, indicating potential for margin improvement.
  • The company's product portfolio spans multiple chemical divisions, with applications in textiles, leather, and water purification.
  • No significant growth or contraction is expected in the near term, with stable revenue performance.
  • Liquidity risk is medium, and dilution risk is low, suggesting a stable capital structure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$17.45B
Gross profit$4.74B
Operating income$918.5M
Net income$185.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.13B
CapEx-$464.5M
Free cash flow$405.1M
Total assets$23.53B
Total liabilities$12.48B
Total equity$11.05B
Cash & equivalents
Long-term debt$9.11B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.05B
Net cash-$9.11B
Current ratio1.2
Debt/Equity0.8
ROA0.8%
ROE1.7%
Cash conversion6.1%
CapEx/Revenue-2.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricBODAActivity
Op margin5.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.1%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin27.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity82.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Last actual EPS1.57 INR
Last actual revenue17,449,360,000 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:22 UTC#6ce80d29
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:24 UTCJob: 12ce6164